Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1595)
Reports (56)
SAGE documentation (225)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (275)
Americas (766)
Eastern Mediterranean (50)
Europe (707)
South-East Asia (81)
Western Pacific (200)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (69)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (131)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (50)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
4872 results found
2020
∙
JCVI
Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 25 September 2020
2020
∙
NACI
Recommendations on the Duration of the Post-vaccination Observation Period for Influenza Vaccination during the COVID-19 Pandemiche COVID-19 Pandemic
2020
∙
NACI
Recommendations on the use of COVID-19 vaccine(s)
2020
∙
NACI
Research priorities for COVID-19 vaccines to support public health decisions
2020
Risk related to spread of new SARSCoV-2 variants of concern in the EU/EEA
2020
∙
WHO
Rubella vaccines: WHO position paper
2020
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Sars-CoV-2 vaccination strategy - Interim recommendations on the vaccination implementation modalities
2020
∙
ATAGI
Statement on the duration of observation after vaccination in the context of minimizing risk of exposure to COVID-19 at health care facilities
2020
∙
Sharon Greene, Blanche-Philomene Melanga Anya, H Asghar, Irtaza Chaudhri, S. Deblina Datta, Morgane Donadel, Koffi Isidore Kouadio, Shefer, Abigail, Kathleen Cavallaro
Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committees
2020
∙
SAGE
Summary of the WHO position on Rubella Vaccine
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register